Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

A systematic comparison of lipopolymers for siRNA delivery to multiple breast cancer cell lines: In vitro studies.

Aliabadi HM, Bahadur K C R, Bousoik E, Hall R, Barbarino A, Thapa B, Coyle M, Mahdipoor P, Uludağ H.

Acta Biomater. 2020 Jan 15;102:351-366. doi: 10.1016/j.actbio.2019.11.036. Epub 2019 Nov 21.

PMID:
31760224
2.

Heterogeneity and Plasticity of Human Breast Cancer Cells in Response to Molecularly-Targeted Drugs.

Bousoik E, Nabiee R, Amirrad F, Nichols A, Witt R, Mahdipoor P, Montazeri Aliabadi H.

Front Oncol. 2019 Oct 15;9:1070. doi: 10.3389/fonc.2019.01070. eCollection 2019.

3.

Amphiphilic Peptides for Efficient siRNA Delivery.

Mozaffari S, Bousoik E, Amirrad F, Lamboy R, Coyle M, Hall R, Alasmari A, Mahdipoor P, Parang K, Montazeri Aliabadi H.

Polymers (Basel). 2019 Apr 17;11(4). pii: E703. doi: 10.3390/polym11040703.

4.

Difatty Acyl-Conjugated Linear and Cyclic Peptides for siRNA Delivery.

Do H, Sharma M, El-Sayed NS, Mahdipoor P, Bousoik E, Parang K, Montazeri Aliabadi H.

ACS Omega. 2017 Oct 31;2(10):6939-6957. doi: 10.1021/acsomega.7b00741. Epub 2017 Oct 19.

5.

Single and Combinational siRNA Therapy of Cancer Cells: Probing Changes in Targeted and Nontargeted Mediators after siRNA Treatment.

Aliabadi HM, Mahdipoor P, Bisoffi M, Hugh JC, Uludağ H.

Mol Pharm. 2016 Dec 5;13(12):4116-4128. Epub 2016 Nov 15.

PMID:
27802596
6.

Effect of siRNA pre-Exposure on Subsequent Response to siRNA Therapy.

Aliabadi HM, Mahdipoor P, Kucharsky C, Chan N, Uludağ H.

Pharm Res. 2015 Dec;32(12):3813-26. doi: 10.1007/s11095-015-1741-z. Epub 2015 Jul 1.

7.

Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines.

Parmar MB, Aliabadi HM, Mahdipoor P, Kucharski C, Maranchuk R, Hugh JC, Uludağ H.

Front Bioeng Biotechnol. 2015 Feb 16;3:14. doi: 10.3389/fbioe.2015.00014. eCollection 2015.

8.

Pharmacokinetics and transgene expression of implanted polyethylenimine-based pDNA complexes.

Rose L, Mahdipoor P, Kucharski C, Uludağ H.

Biomater Sci. 2014 May 7;2(6):833-42. doi: 10.1039/c3bm60200a.

PMID:
26827752
9.

Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy.

Aliabadi HM, Maranchuk R, Kucharski C, Mahdipoor P, Hugh J, Uludağ H.

J Control Release. 2013 Nov 28;172(1):219-228. doi: 10.1016/j.jconrel.2013.08.012. Epub 2013 Aug 30.

PMID:
23994345
10.

Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulation.

Valencia-Serna J, Gul-Uludağ H, Mahdipoor P, Jiang X, Uludağ H.

J Control Release. 2013 Dec 10;172(2):495-503. doi: 10.1016/j.jconrel.2013.05.014. Epub 2013 May 28.

PMID:
23726887
11.

Effective down-regulation of breast cancer resistance protein (BCRP) by siRNA delivery using lipid-substituted aliphatic polymers.

Aliabadi HM, Landry B, Mahdipoor P, Hsu CY, Uludağ H.

Eur J Pharm Biopharm. 2012 May;81(1):33-42. doi: 10.1016/j.ejpb.2012.01.011. Epub 2012 Jan 28.

PMID:
22311298
12.

Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.

Montazeri Aliabadi H, Landry B, Mahdipoor P, Uludağ H.

Mol Pharm. 2011 Oct 3;8(5):1821-30. doi: 10.1021/mp200176v. Epub 2011 Aug 23.

PMID:
21838308
13.

Stability of compounded thioguanine oral suspensions.

Aliabadi HM, Romanick M, Somayaji V, Mahdipoor P, Lavasanifar A.

Am J Health Syst Pharm. 2011 May 15;68(10):900-8. doi: 10.2146/ajhp100163. Erratum in: Am J Health Syst Pharm. 2011 Jul 15;68(14):1278.

PMID:
21546641
14.

A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.

Aliabadi HM, Brocks DR, Mahdipoor P, Lavasanifar A.

J Control Release. 2007 Sep 11;122(1):63-70. Epub 2007 Jun 16.

PMID:
17644207
15.

Insights into the effects of hyperlipoproteinemia on cyclosporine A biodistribution and relationship to renal function.

Aliabadi HM, Spencer TJ, Mahdipoor P, Lavasanifar A, Brocks DR.

AAPS J. 2006 Oct 27;8(4):E672-81. Erratum in: AAPS J. 2006 Dec;8(4):E765. AAPS J. 2006;8(4):E765.

16.

Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading.

Aliabadi HM, Elhasi S, Mahmud A, Gulamhusein R, Mahdipoor P, Lavasanifar A.

Int J Pharm. 2007 Feb 1;329(1-2):158-65. Epub 2006 Aug 22.

PMID:
17008034

Supplemental Content

Loading ...
Support Center